Development of composition and technology of combination drug with neurally mediated action «Memofit»
Journal Title: ScienceRise: Pharmaceutical Science - Year 2017, Vol 0, Issue 6
Abstract
<p> </p><p><strong>Aim. </strong>The aim of this work is to<strong> </strong>develop composition of combination drug in the form of hard-gelatin capsules «Memofit», determine technological and microbiological parameters of intermediate products and ready medicinal product and develop of manufacturing process for capsules «Memofit».<strong></strong></p><p><strong>Methods of the research. </strong>Investigations presented in the article were performed in accordance with the <em>procedures </em>described by the <em>State Pharmacopoeia of Ukraine</em> (SPh Ukraine).<strong></strong></p><p><strong>The results of the research.</strong> Necessity of the development of dietary supplement to provide special dietary properties for the purpose of regulation of functions and systems of the organism within the physiologically normal states under the nervous system dysfunction was substantiated. Results of the study of pharmaco-technological and microbiological parameters of dry extracts that are included as a compound of hard-gelatin capsules «Memofit» were presented. Optimal technological parameters for manufacturing process of capsules «Memofit» were proposed. Results of mass balance for a batch of capsules «Memofit» proved rationality of selected manufacturing process were given. Technology of manufacturing process of capsules «Memofit» was introduced into the production on the TOV “DZ “GNCLS”.<strong></strong></p><p><strong>Conclusions</strong>. Possibility of the development of solid formulations in the form of capsules was established based on the obtained experimental findings of the determination of pharmaco-technological and microbiological parameters of dry extracts. It was shown that capsules «Memofit» are used in dietary food ration as additional source of biologically active substances for promoting normalization of brain function and sleep, improvement of attentiveness. This preparation has general tonic properties and improves mental and physical efficiency. Manufacturing process and process flow chart for this medication was substantiated<strong></strong></p>
Authors and Affiliations
Elena Savelieva, Inna Vladymyrova, Tatyana Tishakova, Olga Levashova
Keywords
Related Articles
- EP ID EP647880
- DOI 10.15587/2519-4852.2017.119744
- Views 169
- Downloads 0
Research of 1,3-oxazole-4-il-phosphonic acid derivative on the content of fatty acids of lipids in rats with arterial hypertension
<p>The number of patients with arterial hypertension (AH) continues to increase. Significant negative effects of arterial hypertension are structural, metabolic and functional disorders in the tissues of the myocardium,...
Risk assessment of logistic activities in foreign economic activity as a component of efficient management by a pharmaceutical company
<p><strong>Aim. </strong>The aim of the study is to develop a methodology for assessing the level of risk of the logistic component of foreign economic activity (FEA) of the pharmaceutical company (PhCo).</p><p><strong>M...
Prediction of the competitiveness dynamics of pharmacy chains
<p>In market economy, one of the main tasks of any enterprise (organization) is to defeat rival competitors. It should not be single or random victory, but it should be natural result of effective management of this proc...
Вивчення летких фракцій сировини рогозу вузьколистого (Typha angustifolia L.)
<p>Рогіз вузьколистий – поширена в багатьох країнах світу, зокрема в Україні, рослина. Дана рослина застосовується для лікування різноманітних захворювань, а саме циститу, уретриту, використовують її як антиоксидантний,...
Первинний аналіз та пріоритезація ризиків процедури біовейвер
<p><strong>Мета</strong><strong>:</strong> Проведення причинно-наслідкового аналізу ідентифікованих ризиків, ранжування та визначення пріоритетів згідно методології загального оцінювання ризиків для забезпечення належног...